Immunomodulation of E.Coli Nissle 1917 in Patients With Grass Pollen Rhinoconjunctivitis

计划入组 34 人 · 首次发布于 2009 年 11 月 13 日

E. Coli Nissle 1917 - Suspension for Infection Prophylaxis

计划入组 567 人 · 首次发布于 2016 年 6 月 16 日

Open Label Trial of Nissle 1917

计划入组 20 人 · 首次发布于 2014 年 10 月 28 日

Escherichia coli strain Nissle 1917

Escherichia coli Nissle 1917 strain

Escherichia coli

BAO PHARMA-B

Orion Corporation

Finland

Comstock Metals Ltd

Australia

Engineered Probiotic Carriers Emerge as Living Drug Factories for Tumor-Targeted Therapy

Synlogic's Novel Probiotic Therapy Shows Promise in Phase 2 PKU Trial, Advancing to Phase 3

IIT Roorkee Researchers Uncover Novel Mechanism of Antibiotic Resistance in E. coli